Insulet (PODD) Cash Flow Statement

Click line-items for a historical chart and %

Cash flows from operating activities
Net loss	-19.76M
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	10.47M
Amortization of debt discount
Stock-based compensation expense	16.85M
Provision for bad debts	1.89M
Non cash interest expense
Impairment of assets
Changes in operating assets and liabilities:
Accounts receivable	2.99M
Inventories	-21.29M
Deferred revenue	-982K
Prepaid expenses and other current assets	-3.27M
Accounts payable, accrued expenses, and other liabilities
Other long term liabilities	756K
Net cash used in operating activities	-4.16M
Cash flows from investing activities
Purchases of property and equipment	-19.21M
Acquisition of Neighborhood Diabetes
Net cash used in investing activities	-80.83M
Cash flows from financing activities
Proceeds from issuance of debt, net of issuance costs
Payments to retire long-term debt	-153.63M
Payment of transaction fees related to credit facility amendment
Proceeds from issuance of common stock, net of offering expenses	4.85M
Net cash provided by financing activities	177.56M
Net decrease in cash and cash equivalents	92.73M
Cash and cash equivalents, beginning of period	122.67M
Cash and cash equivalents, end of period	215.4M
Supplemental disclosure of cash flow information
Cash paid for interest
Non - cash investing and financing activities
Issuance of common stock for the acquisition of Neighborhood Diabetes

Entities mentioned with PODD